ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Sensei Biotherapeutics Inc

Sensei Biotherapeutics Inc (SNSE)

6.52
0.52
(8.67%)
6.52
0.00
( 0.00% )

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
6.52
Bid
6.00
Ask
7.07
Volume
-
0.00 Day's Range 0.00
5.00 52 Week Range 17.40
Market Cap
Previous Close
6.52
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
2,850,910
Shares Outstanding
25,208,068
Dividend Yield
-
PE Ratio
-0.28
Earnings Per Share (EPS)
-1.2
Revenue
-
Net Profit
-30.16M

About Sensei Biotherapeutics Inc

Sensei Biotherapeutics Inc is a clinical-stage immunotherapy company. It is engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer. The company's ImmunoPhage platform is a powerful, self-adjuvanted and highly differentiated immunotherapy ... Sensei Biotherapeutics Inc is a clinical-stage immunotherapy company. It is engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer. The company's ImmunoPhage platform is a powerful, self-adjuvanted and highly differentiated immunotherapy approach that is designed to utilize bacteriophage to induce a robust, focused, and coordinated innate and adaptive immune response. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Dover, Delaware, USA
Founded
-
Sensei Biotherapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SNSE. The last closing price for Sensei Biotherapeutics was $6.52. Over the last year, Sensei Biotherapeutics shares have traded in a share price range of $ 5.00 to $ 17.40.

Sensei Biotherapeutics currently has 25,208,068 shares outstanding. The market capitalization of Sensei Biotherapeutics is $164.36 million. Sensei Biotherapeutics has a price to earnings ratio (PE ratio) of -0.28.

SNSE Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.08-14.21052631587.67.65.62401196.33262353CS
4-0.08-1.212121212126.67.65.251714316.34892661CS
12-2.48-27.5555555556915.19528509109.80644098CS
26-2.18-25.05747126448.715.19515492909.84499168CS
52-6.1-48.335974643412.6217.4589052910.17086046CS
156-30.48-82.37837837843747.8534936912.7433714CS
260-487.48-98.6801619433494527.6527904040.43180341CS

SNSE - Frequently Asked Questions (FAQ)

What is the current Sensei Biotherapeutics share price?
The current share price of Sensei Biotherapeutics is $ 6.52
How many Sensei Biotherapeutics shares are in issue?
Sensei Biotherapeutics has 25,208,068 shares in issue
What is the market cap of Sensei Biotherapeutics?
The market capitalisation of Sensei Biotherapeutics is USD 164.36M
What is the 1 year trading range for Sensei Biotherapeutics share price?
Sensei Biotherapeutics has traded in the range of $ 5.00 to $ 17.40 during the past year
What is the PE ratio of Sensei Biotherapeutics?
The price to earnings ratio of Sensei Biotherapeutics is -0.28
What is the reporting currency for Sensei Biotherapeutics?
Sensei Biotherapeutics reports financial results in USD
What is the latest annual profit for Sensei Biotherapeutics?
The latest annual profit of Sensei Biotherapeutics is USD -30.16M
What is the registered address of Sensei Biotherapeutics?
The registered address for Sensei Biotherapeutics is 800 NORTH STATE STREET, SUITE 304, DOVER, DELAWARE, 19901
What is the Sensei Biotherapeutics website address?
The website address for Sensei Biotherapeutics is www.senseibio.com
Which industry sector does Sensei Biotherapeutics operate in?
Sensei Biotherapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SLRXSalarius Pharmaceuticals Inc
$ 1.63
(160.76%)
4.74M
VERVVerve Therapeutics Inc
$ 11.26
(79.59%)
482.66k
XTIAXTI Aerospace Inc
$ 4.69
(69.31%)
490.43k
JZJianzhi Education Technology Group Company Ltd
$ 4.60
(60.84%)
96.94k
RGCRegencell Bioscience Holdings Ltd
$ 88.00
(46.67%)
49.15k
LDTCLeddarTech Holdings Inc
$ 0.1522
(-26.26%)
83.03k
RUNSunrun Inc
$ 7.285
(-24.43%)
77.51k
SEDGSolarEdge Technologies Inc
$ 19.38
(-19.18%)
20.47k
SNPXSynaptogenix Inc
$ 3.58
(-16.16%)
1
ENPHEnphase Energy Inc
$ 38.90
(-15.31%)
12.03k
GNLNGreenlane Holdings Inc
$ 0.0107
(-13.71%)
7.51M
SLRXSalarius Pharmaceuticals Inc
$ 1.63
(160.76%)
4.74M
HCTIHealthcare Triangle Inc
$ 0.026
(-1.52%)
2.91M
NCNANuCana PLC
$ 0.1349
(2.82%)
2.06M
GTIGraphjet Technology
$ 0.0856
(11.75%)
1.15M

SNSE Discussion

View Posts
glenn1919 glenn1919 3 months ago
SNSE................................https://stockcharts.com/h-sc/ui?s=SNSE&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 3 months ago
SNSE....................................https://www.stockscores.com/charts/charts/?ticker=SNSE
👍️0
tw0122 tw0122 8 months ago
It makes no sense what a pump lol..
👍️0
Monksdream Monksdream 1 year ago
Either that or a lousy result from a clinical trial
👍️0
The Night Stalker The Night Stalker 1 year ago
was there offering
👍️0
Monksdream Monksdream 1 year ago
SNSE under $2
👍️0
Monksdream Monksdream 1 year ago
SNSE under $2
👍️0
Invest-in-America Invest-in-America 2 years ago
SNSE: Not the easiest 'NEWS' to interpret, but nevertheless anything reasonably-POSITIVE about killing CANCER may send it flying-UP in price.
https://finance.yahoo.com/news/sensei-biotherapeutics-reports-favorable-clinical-200500820.html
👍️ 1
Monksdream Monksdream 2 years ago
SNSE new 52 week low
👍️0
Monksdream Monksdream 2 years ago
SNSE new 52 week low
👍️0
Monksdream Monksdream 2 years ago
SNSE new 52 week low
👍️0
Monksdream Monksdream 2 years ago
SNSE new 52 week low
👍️0
Monksdream Monksdream 2 years ago
SNSE new 52 week low
👍️0
Monksdream Monksdream 2 years ago
SNSE new 52 week low
👍️0
Monksdream Monksdream 2 years ago
SNSE new 52 week low
👍️0
Clemdane Clemdane 2 years ago
Anyone else looking at this company? Small anti-aging biotech (senolytics). Affiliated with private Cambrian Biopharma, a large shareholder in SNSE and Tornado Therapeutics which is testing mTOR inhibitors as potential longevity drugs. Will post more DD here. Read about them in Fortune: https://fortune.com/well/2023/02/23/reverse-aging-breakthroughs-in-science/:
👍️0

Your Recent History

Delayed Upgrade Clock